Verition Fund Management
PRVL

Verition Fund Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Verition Fund Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,788
Closed -$310K – 1392
2020
Q2 		$310K Buy
+20,788
New +$310K 0.01% 716